Fed Completed Phase 1 Trials for Etodolac (DB00749)

Also known as: FED

IndicationStatusPhase
DBCOND0052071 (Fed)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01735383Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fed ConditionTreatment